IXC 2.30% 8.5¢ invex therapeutics ltd

Ann: Initial FDA and EMA Advice on Presendin Development, page-3

  1. 550 Posts.
    lightbulb Created with Sketch. 4258
    Very smart move by IXC team to get the boundaries negotiated and set early, increasing chances of approval if the study meets its endpoints.
    All good news as I see it, with a speedier pathway in EU.
    Thumbs up from me.

 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
8.5¢
Change
-0.002(2.30%)
Mkt cap ! $6.388M
Open High Low Value Volume
8.4¢ 8.5¢ 8.4¢ $2.955K 35K

Buyers (Bids)

No. Vol. Price($)
1 94523 8.5¢
 

Sellers (Offers)

Price($) Vol. No.
8.9¢ 58500 1
View Market Depth
Last trade - 12.29pm 29/03/2024 (20 minute delay) ?
Last
8.5¢
  Change
-0.002 ( 1.19 %)
Open High Low Volume
8.5¢ 8.5¢ 8.5¢ 5000
Last updated 12.46pm 29/03/2024 ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.